We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMK icon
1026
Weis Markets
WMK
$1.76B
$1.16M 0.01%
14,834
-26,862
-64% -$1.97M
VITL icon
1027
Vital Farms
VITL
$454M
$1.16M 0.01%
+99,854
New +$1.11M
HLIO icon
1028
Helios Technologies
HLIO
$2.51B
$1.16M 0.01%
+13,011
New +$999K
LFUS icon
1029
Littelfuse
LFUS
$10.5B
$1.16M 0.01%
2,543
-45,844
-95% -$19.8M
CLOV icon
1030
Clover Health Investments
CLOV
$2.2B
$1.16M 0.01%
+220,499
New +$749K
HPK icon
1031
HighPeak Energy
HPK
$1.05B
$1.15M 0.01%
164,873
+88,687
+116% +$612K
SGML icon
1032
Sigma Lithium
SGML
$1.35B
$1.15M 0.01%
+90,846
New +$1.53M
INSP icon
1033
Inspire Medical Systems
INSP
$1.8B
$1.15M 0.01%
+25,704
New +$1.22M
CIFR icon
1034
Cipher Digital
CIFR
$6.55B
$1.14M 0.01%
46,562
-616,188
-93% -$13M
GRAB icon
1035
Grab
GRAB
$14.2B
$1.13M 0.01%
+299,137
New +$1.09M
IOVA icon
1036
Iovance Biotherapeutics
IOVA
$3.76B
$1.13M 0.01%
+270,655
New +$1.03M
FRT icon
1037
Federal Realty Investment Trust
FRT
$10.1B
$1.13M 0.01%
+9,116
New +$1.06M
HWKN icon
1038
Hawkins
HWKN
$2.48B
$1.11M 0.01%
+7,813
New +$1.24M
NTLA icon
1039
Intellia Therapeutics
NTLA
$1.8B
$1.11M 0.01%
65,592
+50,455
+333% +$706K
CAR icon
1040
PUT
Avis
CAR
$5.18B
$1.11M 0.01%
+7,500
New +$1.65M
FCEL icon
1041
FuelCell Energy
FCEL
$1.56B
$1.11M 0.01%
30,757
-79,977
-72% -$1.3M
VXX icon
1042
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$137M
$1.1M 0.01%
+50,000
New +$1.36M
GBX icon
1043
The Greenbrier Companies
GBX
$1.42B
$1.1M 0.01%
+22,488
New +$1.11M
DSGR icon
1044
Distribution Solutions Group
DSGR
$1.61B
$1.1M 0.01%
40,152
+24,511
+157% +$669K
AVAH icon
1045
Aveanna Healthcare
AVAH
$2.87B
$1.09M 0.01%
127,497
-263,228
-67% -$1.86M
ABG icon
1046
Asbury Automotive
ABG
$3.86B
$1.08M 0.01%
5,385
-57,279
-91% -$11.3M
DPRO
1047
CALL
Draganfly
DPRO
$167M
$1.08M 0.01%
+200,000
New +$1.16M
RZLV
1048
Rezolve AI
RZLV
$981M
$1.08M 0.01%
+343,209
New +$903K
EROK
1049
EagleRock Land
EROK
$701M
$1.07M 0.01%
+50,529
New +$1.09M
IIIN icon
1050
Insteel Industries
IIIN
$599M
$1.07M 0.01%
35,460
+13,968
+65% +$400K

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.